RenovoRx, Inc. (RNXT) Tops Q2 EPS by 1c

RenovoRx, Inc. (NASDAQ: RNXT) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $40 thousand versus the consensus estimate of $287.97 thousand.

For earnings history and earnings-related data on RenovoRx, Inc. (RNXT) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• Walmart (WMT) PT Lowered to $130 at Guggenheim
• BMO Capital Starts Analog Devices (ADI) at Outperform